Director's Dealings

RNS Number : 0800O

Futura Medical PLC

05 October 2012

 



For immediate release

5 October 2012

Futura Medical plc

("Futura" or "the Company")

Director's Dealings

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that it has received notification from James Barder, the Chief Executive of the Company, that he and his wife have today gifted in aggregate 50,000 ordinary shares in the Company to a shareholding account jointly held by their children. Although no disposal has taken place for the purposes of the AIM Rules for Companies, Mr Barder's revised aggregate beneficial holding and non-beneficial holdings will now be 925,330 ordinary shares.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

RDSKMMGGFKRGZZM